SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
-16.8%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$784M
AUM Growth
+$784M
(-35%)
Cap. Flow
-$213M
Cap. Flow
% of AUM
-27.15%
Top 10 Holdings %
Top 10 Hldgs %
99.98%
Holding
14
New
1
Increased
4
Reduced
–
Closed
1
Top Buys
| 1 |
Alkermes
ALKS
|
$48.9M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$32.5M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$32.1M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$18.6M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.1M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$357M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $203M | 25.95% | 643,000 | – | – |
|
|
2
Ironwood Pharmaceuticals
IRWD
$214M
| $136M | 17.41% | 13,525,000 +3,218,000 | +31% | +$32.5M |
|
|
3
Alkermes
ALKS
$4.78B
| $104M | 13.23% | 7,193,000 +3,388,000 | +89% | +$48.9M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $82.8M | 10.56% | 467,500 | – | – |
|
|
5
Jazz Pharmaceuticals
JAZZ
$7.75B
| $76.3M | 9.73% | 765,000 +321,500 | +72% | +$32.1M |
|
6
Innoviva
INVA
$1.29B
| $73.4M | 9.36% | 6,242,000 | – | – |
|
|
ICPT
7
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $72.7M | 9.28% | 1,155,000 +295,000 | +34% | +$18.6M |
|
8
Mersana Therapeutics
MRSN
$36.5M
| $21.9M | 2.79% | 3,750,000 | – | – |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.1M | 1.55% | +135,000 | New | +$12.1M |
|
|
RGLS
10
DELISTED
Regulus Therapeutics
RGLS
| $853K | 0.11% | 1,851,851 | – | – |
|
11
AbbVie
ABBV
$372B
| $76K | 0.01% | 1,000 | – | – |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $76K | 0.01% | 1,000 | – | – |
|
|
MDCO
13
DELISTED
Medicines Co
MDCO
| – | – | -4,202,000 | Closed | -$357M |
|